Description: Endurance RP Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in the People's Republic of China, Europe, Hong Kong, and Taiwan. The company operates in two segments, Biopharma and Corporate Investment. It engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management and corporate finance services. The company was formerly known as Regent Pacific Group Limited and changed its name to Endurance RP Limited in June 2021. Endurance RP Limited was incorporated in 1991 and is headquartered in Central, Hong Kong.
Home Page: www.regentpac.com
Henley Building
Central,
Hong Kong
Phone:
852 2514 6111
Officers
| Name | Title |
|---|---|
| Mr. Jamie Alexander Gibson | CEO & Executive Director |
| Dr. Michael Grant Wyllie BSc, D.Sc., DSc | Co-Founder & Chief Scientific Officer |
| Mr. Yui Fui Wong | Chief Financial Officer |
| Mr. Paul Eric Jones BA, MBA | Investment Director |
| Ms. Mei Yan Lui | Company Secretary |
| Prof. John Michael Fitzpatrick FC Urol (SA), FRCS, FRCSGlas, FRCSI, MCh | Chairman of Clinical Scientific Advisory Board |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Financials |
|---|---|
| GIC Group: | Financial Services |
| GIC Industry: | Capital Markets |
| GIC Sub-Industry: | Asset Management & Custody Banks |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.9484 |
| Price-to-Sales TTM: | 216.0329 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 17 |